Tower Research Capital (TRC)’s Fidelity Disruptive Medicine ETF FMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-162
| Closed | -$4K | – | 5387 |
|
|
2024
Q4 | $4K | Hold |
162
| – | – | ﹤0.01% | 4545 |
|
|
2024
Q3 | $4.26K | Hold |
162
| – | – | ﹤0.01% | 4621 |
|
|
2024
Q2 | $3.9K | Hold |
162
| – | – | ﹤0.01% | 4845 |
|
|
2024
Q1 | $4.13K | Hold |
162
| – | – | ﹤0.01% | 4732 |
|
|
2023
Q4 | $3.92K | Buy |
162
+50
| +45% | +$1.21K | ﹤0.01% | 5026 |
|
|
2023
Q3 | $2.48K | Buy |
+112
| New | +$2.48K | ﹤0.01% | 5143 |
|